201 related articles for article (PubMed ID: 32022993)
1. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
[TBL] [Abstract][Full Text] [Related]
2. Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.
Mukai N; Doi Y; Ninomiya T; Hata J; Yonemoto K; Iwase M; Iida M; Kiyohara Y
Diabetes Care; 2009 Dec; 32(12):2288-93. PubMed ID: 19729523
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
5. Risk of type 2 diabetes according to the cumulative exposure to metabolic syndrome or obesity: A nationwide population-based study.
Lee YB; Kim DH; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Han K; Yoo HJ
J Diabetes Investig; 2020 Nov; 11(6):1583-1593. PubMed ID: 32449283
[TBL] [Abstract][Full Text] [Related]
6. Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1.
Sakane N; Kotani K; Suganuma A; Takahashi K; Sato J; Suzuki S; Izumi K; Kato M; Noda M; Nirengi S; Kuzuya H
J Occup Health; 2020 Jan; 62(1):e12109. PubMed ID: 32515888
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
8. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
[TBL] [Abstract][Full Text] [Related]
9. The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome.
Rodrigues S; Cepeda FX; Toschi-Dias E; Dutra-Marques ACB; Carvalho JC; Costa-Hong V; Alves MJNN; Rondon MUPB; Bortolotto LA; Trombetta IC
J Clin Hypertens (Greenwich); 2017 Sep; 19(9):840-847. PubMed ID: 28868764
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus.
Cho NH; Ahn CH; Moon JH; Kwak SH; Choi SH; Lim S; Park KS; Metzger BE; Jang HC
Medicine (Baltimore); 2016 Aug; 95(35):e4582. PubMed ID: 27583868
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
12. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
13. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in first degree relatives of patients with type 2 diabetes: Incidence and risk factors.
Janghorbani M; Amini M
Diabetes Metab Syndr; 2011; 5(4):201-6. PubMed ID: 25572763
[TBL] [Abstract][Full Text] [Related]
15. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
[TBL] [Abstract][Full Text] [Related]
16. Changes in diabetes prevalence and corresponding risk factors - findings from 3- and 6-year follow-up of PURE Poland cohort study.
Zatońska K; Basiak-Rasała A; Różańska D; Karczewski M; Wołyniec M; Szuba A; Połtyn-Zaradna K
BMC Public Health; 2020 Jun; 20(1):843. PubMed ID: 32493306
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia and metabolic syndrome at mean age of 10 years in black and white schoolgirls and development of impaired fasting glucose and type 2 diabetes mellitus by mean age of 24 years.
Morrison JA; Glueck CJ; Umar M; Daniels S; Dolan LM; Wang P
Metabolism; 2011 Jan; 60(1):24-31. PubMed ID: 20096893
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
[TBL] [Abstract][Full Text] [Related]
19. Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.
Mitsuhashi K; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukuda T; Fukui M
Endocr J; 2017 Nov; 64(11):1105-1114. PubMed ID: 28867686
[TBL] [Abstract][Full Text] [Related]
20. Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men.
Lee DC; Sui X; Church TS; Lee IM; Blair SN
Diabetes Care; 2009 Feb; 32(2):257-62. PubMed ID: 18984778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
